Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06596512Not yet recruiting
Randomised, open-label trial in asthma (4 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Asthma Exacerbations at 16 months. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06596512.